Table 2. Selected therapeutic regimens of pembrolizumab.
| Daily dose | Route of administration | Administered on day(s) | Cycle length, days | Total dose/cycle | Reference |
| 2 mg/kga | IV | 1 | 21 | 2 mg/kg | 11-13,15-19 |
| 10 mg/kg | IV | 1 | 14 | 10 mg/kg | 12,15,16,19 |
| 10 mg/kg | IV | 1 | 21 | 10 mg/kg | 11,12,15,17-19 |
Note: IV = intravenous.
Conforms to dosing information listed in manufacturer’s labeling.